UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 8/2023

Jun 12, 2023·EP2628464 · PROSTHETIC VALVE

Follow
Case details
Status
Case Closed (Settled)
Action
Infringement
Category
Main infringement action
Parties
Claimants
Representatives
Respondents
Representatives
Division
Nordic-Baltic RD
Judges
Technology
  • Instruments
    Medical technology
Language
English
EPO Opposition
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Infringement foundMedian days to first decision
All UPC53% (62/117)124
Nordic-Baltic RDLockedLocked
Judge Stefan JohanssonLockedLocked
Judge Kai HärmandLockedLocked
Judge Rute LopesLockedLocked
Judge Elisabetta PapaLockedLocked

At the UPC: Edwards Lifesciences Group (57 cases)·Meril Group (60 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

This dispute contains 2 other proceedings

CC 587594/2023·UPC APP 43606/2024

1 other defendants litigating the same or a related patent

UPC CFI 732/2024

Start a free trial to see how each one ended.

More cases: Nordic-Baltic RD·2023

Decisions
  • 2025-07-21
    Application RoP 365Public

    Summary: The court confirmed a settlement agreement between Edwards Lifesciences Corporation and the Meril defendants (Meril Lifesciences PVT Limited, Meril GmbH, SMIS International OÜ, and Sormedica UAB) in the infringement action and related counterclaims for revocation concerning EP 2 628 464. Both the infringement action and counterclaims for revocation were settled and confirmed by decision. The court also ordered partial reimbursement of court fees.

    Show the legal issues (3)
    • Confirmation of settlement agreement (Rule 365 RoP)
    • Settlement of infringement action and counterclaims for revocation
    • Partial reimbursement of court fees
Documents
Show all 780 documents
Document titleDatePublic
Case closed2025-09-26Not public
Headnote-and-Keywords2025-07-18Not public
Outcome of the Order2025-07-18Not public
Settlement Decision2025-07-18Not public
Settlement Decision2025-07-18Public
Comments2025-07-17Not public
Comments2025-07-17Not public
Comments2025-07-17Not public
Comments2025-07-17Not public
Procedural order2025-07-14Not public
Coverage: Thin.Reasoning extracted with limited coverage — see decisions tab for full text.
Plain-English summary

Edwards Lifesciences Corporation brought a UPC infringement action before the Nordic-Baltic Regional Division against Meril Lifesciences and related entities concerning EP 2628464 (a prosthetic heart valve), with defendants filing counterclaims for revocation. Following a stay pending EPO Technical Board of Appeal proceedings (TBA upheld the patent in June 2024), the parties reached a confidential settlement agreement in July 2025. The court confirmed the settlement by decision covering both the infringement action and all four counterclaim workflows, and ordered partial reimbursement of court fees.

Accepted arguments
What the court agreed with — by party.

No accepted arguments captured.

Rejected arguments
What the court did not agree with — and why.

No rejected arguments captured.

Key legal principles
Doctrines and rules cited in the reasoning.
Parties may settle and dispose of proceedings without seeking a court-confirmatory decision under Rule 365 RoPSettlement confirmed by court decision can cover both infringement action and counterclaims for revocation20% court fee reimbursement available on settlement under Rule 370.9(c) RoP

Browse other cases on this principle.